Dovato

Product NDC
49702-246
11-digit product format
497020246
Labeler code
49702
Product ID
49702-246_9b88da25-ebce-49ae-8c8a-dcee6f465957
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dolutegravir sodium and lamivudine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
ViiV Healthcare Company
Application
NDA211994
Marketing category
NDA
Marketing start
2019-04-08
Substance
DOLUTEGRAVIR SODIUM; LAMIVUDINE
Active strength
50; 300 mg/1; mg/1
Pharmacologic classes
HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Dovato
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DOLUTEGRAVIR SODIUM50 mg/1
LAMIVUDINE300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii1Q1V9V5WYQ, 2T8Q726O95
Rxcui2122519, 2122526

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
aaa99659-c62c-7281-d402-9590409850c2Product name620260128
a02e6d35-8cc4-a80a-fd4d-d3ec16f69b8eProduct name820250626
4ef90d80-1289-4267-a2bb-01c741d1208fProduct name120230829
72dcca4e-6eae-4149-a92b-264c2a07004fProduct name120230808
3832141c-c294-474a-9473-1052c891450eProduct name220230105
320f244d-8b4e-4893-9f14-104b2a8e0aafProduct name220201007
7ff71f22-5b66-4a3d-bf64-671893a6409dProduct name220201007
3644e9cf-6f4d-4b63-b875-6a4b5187c47eProduct name120190703
0e579b5c-f0b5-e690-466e-4a5e809e2c68Product name320190627
6f122144-2ceb-48fa-a906-0d2eb742717eProduct name120190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67Product name120181211
fbdbfbef-2c33-0298-4fef-f6693e670fe1Product name720181210
d07e0b9e-e041-41dc-942a-a2a6601dc221Product name120181029
44633898-5724-4273-abcc-3541a1107946Product name120180124
af19b329-4f44-cd81-491a-fbb7fe7a079fProduct name220151013
c873f14e-2add-4d53-b9b3-bf775efd3702Product name120150325
7d3f81af-5024-0cff-2664-d433b7688444Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49702-246-13Dovato30 in 1 BOTTLETABLET, FILM COATED3019
49702-246-33Dovato1 in 1 CARTONTABLET, FILM COATED119
49702-246-33Dovato30 in 1 BLISTER PACKTABLET, FILM COATED3019
49702-246-62Dovato14 in 1 BLISTER PACKTABLET, FILM COATED1419
49702-246-62Dovato1 in 1 CARTONTABLET, FILM COATED119

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49702-246-13EA - Each49702-246153309ea-c2f7-44e2-a073-9a6f5e07b61812019-05-02
49702-246-33EA - Each49702-24679eee8a9-4c99-4f12-bb03-04c3bf74230d12024-02-14
49702-246-61EA - Each49702-2463e24b0ec-8017-4e37-bde3-16878ce8ff4e12025-12-16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49702-246DOVATO (DOLUTEGRAVIR SODIUM AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]16Current NDC, Legacy NDC, 5 package rows20240921_68e45422-43ed-4cfb-9356-fae88d14a53a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2122519dolutegravir 50 MG / lamiVUDine 300 MG Oral TabletPSN68e45422-43ed-4cfb-9356-fae88d14a53a19
2122526Dovato 50 MG / 300 MG Oral TabletPSN68e45422-43ed-4cfb-9356-fae88d14a53a19
2122526dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Dovato]SBD68e45422-43ed-4cfb-9356-fae88d14a53a19
2122519dolutegravir 50 MG / lamivudine 300 MG Oral TabletSCD68e45422-43ed-4cfb-9356-fae88d14a53a19
2122519dolutegravir 50 MG (equivalent to 52.6 MG dolutegravir sodium) / lamivudine 300 MG Oral TabletSY68e45422-43ed-4cfb-9356-fae88d14a53a19
2122519dolutegravir 50 MG / 3TC 300 MG Oral TabletSY68e45422-43ed-4cfb-9356-fae88d14a53a19
2122526dolutegravir 50 MG / 3TC 300 MG Oral Tablet [Dovato]SY68e45422-43ed-4cfb-9356-fae88d14a53a19
2122526Dovato (dolutegravir 50 MG (equivalent to 52.6 MG dolutegravir sodium) / lamivudine 300 MG) Oral TabletSY68e45422-43ed-4cfb-9356-fae88d14a53a19

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
49702-246-134970202461330 TABLET, FILM COATED in 1 BOTTLE (49702-246-13) 2019-04-080000-00-00NoNoCurrent
49702-246-33497020246331 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2024-01-01NoNoCurrent
49702-246-614970202466114 TABLET, FILM COATED in 1 BOTTLE (49702-246-61) 2019-08-060000-00-00NoNoCurrent
49702-246-62497020246621 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2024-01-01NoNoCurrent